Secondary Marketplace / Trade Private Companies / Buy and Sell Heal Stock
Heal Heal Stock
$134.37MM
Series E Valuation, Oct 2021
Register To Buy and Sell Private Company Shares
For more details on financing and valuation of private companies similar to Heal before its M&A, register or login today.
Please provide a valid email address.
By registering, you agree to Forge’s Terms of Use. Already registered? Sign in

Heal Stock Price

Forge Price 1
Price not available
Last Closed Trade 2
Close Date
xx/xx/xx
Last Closed Trade Price
$xx.xx
Last Funding Round (LFR)
Date
xx/xx/xx
Price per Share
$xx.xx

Heal Funding Rounds and Valuation

Funding History Chart
Funding Round Details
Funding Date Share Class Amount Raised Price per Share Post-Money Valuation Key Investors
10/21/2021 Series E $4.5MM $xx.xx $134.37MM Undisclosed Investors
Price per Share
$xx.xx
Shares Outstanding
140,143,257
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
07/29/2020 Series D-1 $47.43MM $xx.xx $119.75MM Humana
Price per Share
$xx.xx
Shares Outstanding
1,688,983,847
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Humana
07/29/2020 Series D-2 $15MM $xx.xx $119.75MM Humana
Price per Share
$xx.xx
Shares Outstanding
467,144,192
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Humana
05/28/2018 Series C $16.15MM $xx.xx $38.3MM Bascom Ventures, Inflection Capital, Ira Capital, Lionel Richie, Rlj Equity Partners, Trans-Pacific Technology Fund
Price per Share
$xx.xx
Shares Outstanding
522,965,858
Liquidation Pref Order
4
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Bascom Ventures, Inflection Capital, Ira Capital, Lionel Richie, Rlj Equity Partners, Trans-Pacific Technology Fund
10/18/2016 Series B $21.64MM $xx.xx $110MM Breyer Capital, David Ellison, Hashtag One, Paul Jacobs, Slow Ventures, Tull Investment Group
Price per Share
$xx.xx
Shares Outstanding
70,927,666
Liquidation Pref Order
5
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
9.0%
Cumulative
Cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Breyer Capital, David Ellison, Hashtag One, Paul Jacobs, Slow Ventures, Tull Investment Group
06/23/2015 Series A $69.64MM $xx.xx $87.05MM March Capital, Pritzker Capital, Slow Ventures
Price per Share
$xx.xx
Shares Outstanding
244,320,343
Liquidation Pref Order
5
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.6x
Dividend Rate
8.0%
Cumulative
Cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
March Capital, Pritzker Capital, Slow Ventures
Company Details
Heal is a digital health company offering modern doctor house calls, one-touch telemedicine for primary care, chronic disease management, sick visits and urgent care.
Founded
2014
Post-Money Valuation 3
$134.37MM
Total Funding
$174.35MM
LFR Price per Share
$xx.xx
Last Funding Share Class
Series E
Heal Stock FAQs
To buy and sell Heal stock
Can you buy Heal stock?
You can no longer buy Heal stock on a secondary marketplace as this company is no longer private. If you are interested in buying stock of other private companies, learn more about how to invest in the private market or register today to get started.
How to buy Heal stock?
You can no longer buy Heal stock on a secondary marketplace as this company is no longer private. If you are interested in buying stock of other private companies, learn more about how to invest in the private market or register today to get started.
Can you sell Heal stock?
You can no longer sell stock of Heal on Forge as this company is no longer private. However, if you own stock of a private company, Forge may help you sell it in a way that works for you and the company. Learn more or register with us today to get started.
How to sell Heal stock?
You can no longer sell stock of Heal on Forge as this company is no longer private. However, if you own stock of a private company, Forge may help you sell it in a way that works for you and the company. Learn more or register with us today to get started.
To learn more about Heal stock
Is Heal a public company?
Heal is now a public company.
What is Heal’s stock price?
The stock price of Heal is not currently available.
What is Heal’s stock ticker symbol?
The ticker symbol of Heal is not currently available.
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

Heal Investors Also Invested in These Private Companies

Paul Jacobs
Trans-Pacific Technology Fund
Inflection Capital
Rlj Equity Partners
Bascom Ventures
Lionel Richie
Ira Capital
Hashtag One
Pritzker Capital
Tull Investment Group
David Ellison

Leadership & Board

Leadership

Greg Drobnick
Co-Founder & Executive Vice President Strategic Initiatives
Renee Dua
Co-Founder & Chief Medical Officer
Nick Desai
Co-Founder, Chief Executive Officer & Board Member

Board

Richard Gephardt JD
Thomas Tull
Tull Financial Group
Nick Desai
Michael Wortsman

Heal News and Media Highlights

Heal raises $100 million for telehealth appointments and house calls

Heal, a health care platform that enables patients to arrange physical house calls from doctors, has raised $100 million from insurance giant Humana. 

Humana partners with Heal and invests $100 million in the company’s doctor-on-demand service – TechCrunch

“The doctor’s office is dead.” That’s the way Nick Desai, the co-founder and chief executive of the Los Angeles-based startup Heal, describes the future of traditional healthcare delivery. While Desai’s bluster may be wishful thinking, the doctor’s office is cert…

Humana invests $100 million in telehealth start-up Heal

Humana announced Wednesday that it's partnering with telehealth start-up Heal, which includes a $100 million investment that allows the two companies to deliver primary-care services to Humana members in the comfort of their own home.

Heal Lands $100M From Humana For At-Home Care Model 

The Series D round brings Heal’s total funding to $200 million and gives the company a post-money valuation of at least $300 million.
Browse Insights
Other Companies Like Heal in the Digital Health Sector
Sector: Healthcare
Subsector: Digital Health
Last Funding Round
Company Forge Price Forge Price Change 5 Last Closed Trade Share Class Post-Money Valuation Price per Share Amount Raised
BetterUpBetterUp$2.04-37.04%$xx.xxSeries E$4.75B$xx.xx$340MM
BrightlineBrightline----$xx.xxSeries C$705.25MM$xx.xx$115.2MM
CalmCalm$2.38-34.25%$xx.xxSeries 1$404.67MM$xx.xx$25.07MM
HeadspaceHeadspace$3.77-15.66%$xx.xxSeries B$298.33MM$xx.xx$38.65MM
Hinge HealthHinge Health$31.00-22.11%$xx.xxSeries E$6.2B$xx.xx$400MM
Included HealthIncluded Health$1.30-3.70%$xx.xxSeries E$1.13B$xx.xx$103.04MM
NoomNoom$12.56-10.22%$xx.xxSeries F$3.66B$xx.xx$525.46MM
OURAOURA----$xx.xx--------
Omada HealthOmada Health$3.30-20.29%$xx.xxSeries E$1.02B$xx.xx$192MM
ZocDocZocDoc$7.50-6.13%$xx.xxSeries D-2$2.62B$xx.xx$100MM

Updated on: Jan 22, 2025

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

  1. Forge Price™ is a custom data-point calculated and disseminated by Forge Data LLC (“Forge Data”) and is a mark of Forge Data. Forge Price may rely on a very limited number of inputs in its calculation. Forge Price is prepared and disseminated solely for informational purposes. Redistribution is permitted solely with Forge’s written consent. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of Forge Price, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of Forge Price. Forge Price is derived from secondary activity on the Forge platform and other private market trading platforms, and other publicly-available datapoints collected by Forge. Forge Price is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Neither reference to company names, nor calculation of Forge Price for a specific company, implies any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company. The dollar-figure and percentage displayed indicates the per share change in dollar amount and percentage since the most recent Forge Price change. Percentages are rounded to the nearest whole number.
  2. The Last Closed Trade price displayed reflects the price at which the last trade in this company's security occurred on Forge, and can include secondary trades in any class of the company's security, or trades in units of funds holding the company's securities (the economics of which differ versus direct company ownership). The date displayed reflects the date on which the last trade in this company's security closed on Forge. This may be several weeks after the terms of the trade were agreed upon between the buyer and seller. In case of multiple trades closed on the same date, the price displayed is of either (i) the trade which terms were agreed upon most recently; or (ii) the trade with the higher notional value.
  3. Post-Money Valuation represents the estimated valuation based on company-submitted Certificates of Incorporations (COIs).
  4. Last Known Valuation represents a valuation gathered from non-COI, publicly available sources including company press releases or multiple concurring news articles.
  5. The dollar-figure and percentage displayed indicates the per share change in dollar amount and percentage since the most recent Forge Price change. Percentages are rounded to the nearest whole number.

‘Stock Price’ or other private company metrics (‘PC Data’) may rely on a very limited number of trade and/or IOI inputs in their calculation. PC Data is prepared and disseminated solely for informational purposes. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of PC Data, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of PC Data. PC Data is derived from the performance and pricing of secondary activity on the Forge platform and other private market trading platforms. PC Data is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Reference to company names does not imply any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company.

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.

Investing in private company securities is not suitable for all investors, is highly speculative, is high risk, and investors should be prepared to withstand a total loss of their investment. Private company securities are highly illiquid and there is no guarantee that a market will develop for such securities. Each investment carries its own risks, and investors should conduct their own due diligence regarding the investment, including obtaining independent professional advice. Past performance is not indicative of future results. This is not a recommendation, offer, solicitation of an offer, or advice to buy or sell securities by Forge, nor an offer of brokerage services in any jurisdiction where Forge is not permitted to offer brokerage services. Brokerage products and services are offered by Forge Securities LLC, a registered broker-dealer and member FINRA/SIPC. Please see other important disclaimers, disclosures and restrictions you acknowledge by using this website and to which you are subject.